As of 2025-05-21, the Intrinsic Value of Virbac SA (VIRP.PA) is 360.15 EUR. This VIRP.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 312.50 EUR, the upside of Virbac SA is 15.20%.
The range of the Intrinsic Value is 264.28 - 571.01 EUR
Based on its market price of 312.50 EUR and our intrinsic valuation, Virbac SA (VIRP.PA) is undervalued by 15.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 264.28 - 571.01 | 360.15 | 15.2% |
| DCF (Growth 10y) | 320.43 - 649.69 | 424.09 | 35.7% |
| DCF (EBITDA 5y) | 235.78 - 310.39 | 278.68 | -10.8% |
| DCF (EBITDA 10y) | 297.72 - 396.61 | 350.85 | 12.3% |
| Fair Value | 1,725.74 - 1,725.74 | 1,725.74 | 452.24% |
| P/E | 275.33 - 1,194.21 | 697.53 | 123.2% |
| EV/EBITDA | 211.79 - 746.35 | 474.74 | 51.9% |
| EPV | 417.65 - 540.01 | 478.83 | 53.2% |
| DDM - Stable | 659.85 - 1,798.46 | 1,229.15 | 293.3% |
| DDM - Multi | 214.79 - 457.62 | 292.65 | -6.4% |
| Market Cap (mil) | 2,621.88 |
| Beta | 0.62 |
| Outstanding shares (mil) | 8.39 |
| Enterprise Value (mil) | 2,779.26 |
| Market risk premium | 5.82% |
| Cost of Equity | 7.39% |
| Cost of Debt | 4.25% |
| WACC | 6.93% |